Download PDF
CC BY 4.0 · Journal of Child Science 2022; 12(01): e148-e151
DOI: 10.1055/s-0042-1757153
Case Report

An Unusual Clinical Presentation of Budd–Chiari Syndrome in an Adolescent Boy

Shreyash Agrawal
1   MBBS Student, VMMC and Safdarjung Hospital, New Delhi, India
,
Garima Pathania
2   Department of Pediatrics, VMMC and Safdarjung Hospital, New Delhi, India
,
Richa Mittal
2   Department of Pediatrics, VMMC and Safdarjung Hospital, New Delhi, India
,
Sumit Mehndiratta
2   Department of Pediatrics, VMMC and Safdarjung Hospital, New Delhi, India
,
Amitabh Singh 
2   Department of Pediatrics, VMMC and Safdarjung Hospital, New Delhi, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

We report an unusual case of massive splenomegaly with pancytopenia without ascites, which was referred to us with suspicion of a myeloproliferative disorder in an adolescent boy. The work-up done was noncontributory to a hematological disorder. On further work-up, liver biopsy depicted sinusoidal congestion, with Doppler study suggestive of nonvisualization of hepatic veins. There was hypertrophy of the right lobe and the presence of venovenous collaterals. Janus kinase 2 (JAK2) V617F mutation was negative, which confirmed the absence of unidentified myeloproliferative disorder. This was an atypical presentation of Budd–Chiari syndrome (BCS) in children. The absence of ascites could be due to more efficient collateral formation in adolescent age groups due to angiogenesis. Underlying thrombophilia was detected as methylenetetrahydrofolate reductase mutation 677C > T with raised serum homocysteine levels. It is imperative to be aware of the diverse clinical manifestations in children for early detection and appropriate intervention to prevent catastrophic results in pediatric BCS.

Keywords

Budd–Chiari syndrome - hypersplenism - myeloproliferative disorder - children - thrombophilia

Authors' Contributions

S. A. and G. P. supported in data collection, data analysis, and preparing the first draft of the manuscript. R. M. and S. M. contributed in editing and preparing the second draft of the manuscript. A. S. dedicated to supervision and editing. All authors approved of the final manuscript.


Note

All authors have substantial contributions to the conception and design of the work and preparing and revising the draft critically for important intellectual content. All authors have approved the final version of the manuscript and are accountable for all aspects of the work.




Publication History

Received: 09 March 2022

Accepted: 31 July 2022

Article published online:
07 October 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003; 38 (04) 793-803
    CrossrefPubMedSearch in Google Scholar
  • 2 Gentil-Kocher S, Bernard O, Brunelle F. et al. Budd-Chiari syndrome in children: report of 22 cases. J Pediatr 1988; 113 (1 Pt 1): 30-38
    CrossrefPubMedSearch in Google Scholar
  • 3 Dilawari JB, Bambery P, Chawla Y. et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994; 73 (01) 21-36
    CrossrefPubMedSearch in Google Scholar
  • 4 Shukla A, Bhatt P, Gupta DK. et al. Budd-Chiari syndrome has different presentations and disease severity during adolescence. Hepatol Int 2018; 12 (06) 560-566
    CrossrefPubMedSearch in Google Scholar
  • 5 Miller WJ, Federle MP, Straub WH, Davis PL. Budd-Chiari syndrome: imaging with pathologic correlation. Abdom Imaging 1993; 18 (04) 329-335
    CrossrefPubMedSearch in Google Scholar
  • 6 Chawla Y, Kumar S, Dhiman RK, Suri S, Dilawari JB. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 1999; 14 (09) 904-907
    CrossrefPubMedSearch in Google Scholar
  • 7 Haque LYK, Lim JK. Budd-Chiari syndrome: an uncommon cause of chronic liver disease that cannot be missed. Clin Liver Dis 2020; 24 (03) 453-481
    CrossrefPubMedSearch in Google Scholar
  • 8 Rivard A, Fabre JE, Silver M. et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99 (01) 111-120
    CrossrefPubMedSearch in Google Scholar
  • 9 Plessier A, Sibert A, Consigny Y. et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44 (05) 1308-1316
    CrossrefPubMedSearch in Google Scholar
  • 10 Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol 2010; 29 (01) 8-11
    CrossrefPubMedSearch in Google Scholar
  • 11 Kathuria R, Srivastava A, Yachha SK, Poddar U, Baijal SS. Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome. Eur J Gastroenterol Hepatol 2014; 26 (09) 1030-1038
    CrossrefPubMedSearch in Google Scholar
  • 12 Li XM, Wei YF, Hao HL. et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol 2002; 71 (01) 11-14
    CrossrefPubMedSearch in Google Scholar